hsa-miR-185

ncRNA information

ncRNA name

hsa-miR-185

Specific or universal ncRNAs

Universal ncRNAs

Class

MicroRNA

Biomarker

No

Biomarker application

Upstream regulatory factors

ZNF139

Downstream target

Not available

Cancer information

Cancer name

Gastric Cancer

Cancer site

Stomach

Treatment information

Treatment type

Chemotherapy

Drug

5-Fluorouracil/Adriamycin

Impact of wild-type ncRNA on chemotherapy resistance

Impact of knockdown of ncRNA on chemotherapy resistance

Up

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

Transfection with pcDNA-ZNF139 in GC cell line SGC7901 resulted in an increased expression level of ZNF139 and a decline in the expression level of miR-185.

Tissue resource

clinical samples of gastric cancer and para-cacinoma tissues

human gastric cancer cell lines GES-1

human gastric cancer cell lines SGC7901

gastric cancer adriamycin-resistant cell lines SGC7901/ADR

Experiment

qRT-PCR,Western blot,Luciferase reporter assay


Institute

The Fourth Hospital of Hebei Medical University

Shanghai Institutes of Biochemistry and Cell Biology

The Fourth Hospital of Hebei Medical University

Country

China

Continent

Asia